Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Oxytocin on Opioid Withdrawal Symptoms
2010-023208-29Phase 2Completed
- Sponsor
- University of Bonn
- Start
- Dec 2010
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, single-arm trial of oxytocin in opioid use disorder (OUD), sponsored by University of Bonn. Primary endpoint: Reduction in opioid withdrawal symptoms during detoxification. Started Dec 2010; status: completed.
02
Drugs
oxytocin
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on 2010-023208-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023208-29.